Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite.
The BBC recently did a complete hit job on ivermectin—not surprising given the money circulating to ensure such events occur as planned. Among the many inaccuracies the BBC proclaims up to a third of the ivermectin studies as probable frauds, yet they have no basis to make such a claim. In fact, the BBC’s critique in part rests on the work of a questionable group. One that while seemingly innocently muckraking, execute an agenda.
The center of the BBC critique used to bash dozens of studies including a study favoring ivermectin in Egypt led by Elgazzar et al. Yes, the public British broadcaster’s thrust against the drug is based on a questionable investigation into this study. One that led to the pulling of the preprint write-up and 24 hours with no consultation to the author—by no means a reasonable amount of time—then a bashing by a major newspaper. Smells like a setup.
What follows is a letter from Dr. Tess Lawrie, Ph.D. director of the British Ivermectin Recommendation Development Group (BIRD) to Jack Goodman, a journ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).